Buckwheat concentrate reduces serum glucose in streptozotocin-diabetic rats.
@article{Kawa2003BuckwheatCR, title={Buckwheat concentrate reduces serum glucose in streptozotocin-diabetic rats.}, author={Julianne M Kawa and Carla G. Taylor and Roman Przybylski}, journal={Journal of agricultural and food chemistry}, year={2003}, volume={51 25}, pages={ 7287-91 } }
The antihyperglycemic effects of chemically synthesized d-chiro-inositol (d-CI), a component of an insulin mediator, have been demonstrated in rats. Buckwheat contains relatively high levels of d-CI: thus, it has been proposed as a source of d-CI for reducing serum glucose concentrations in diabetics. The present study evaluates the effects of a buckwheat concentrate, containing d-CI, on hyperglycemia and glucose tolerance in streptozotocin (STZ) rats. In fed STZ rats, both doses of the…
149 Citations
Hypoglycemic and hepatoprotective effects of D-chiro-inositol-enriched tartary buckwheat extract in high fructose-fed mice.
- Biology, ChemistryFood & function
- 2015
Findings are the first to demonstrate that the intake of DTBE may be a feasible preventive or therapeutic strategy for HF diet-induced hyperglycemia, hepatic steatosis and oxidative injury.
Extracts of common buckwheat bran prevent sucrose digestion.
- Chemistry, MedicineJournal of nutritional science and vitaminology
- 2011
The data indicate that components of BBE other than rutin have inhibitory activity against sucrase in vivo, and suggest that BBE could have beneficial effects on diabetes.
D-chiro-inositol-enriched tartary buckwheat bran extract lowers the blood glucose level in KK-Ay mice.
- Chemistry, MedicineJournal of agricultural and food chemistry
- 2008
Oral administration of DCI-enriched TBBE could lower plasma glucose, C-peptide, glucagon, triglyceride, and BUN, improve glucose tolerance, and enhance insulin immunoreactivity in KK-A(y) mice.
EVALUATION OF BUCKWHEAT FOR MANAGEMENT OF DIABETES
- MedicinePakistan Journal of Public Health
- 2020
It was indicated that the oral administration of CBE and TBE could lower the blood glucose level and can increase glucose tolerance effectively and demonstrated that TBF contains higher nutritional contact as compared to CBF.
Antihypertensive effects of Tartary buckwheat flavonoids by improvement of vascular insulin sensitivity in spontaneously hypertensive rats.
- Medicine, BiologyFood & function
- 2017
Quercetin was identified as the predominant active component of TBF in attenuating the development of hypertension with regard to reducing vascular oxidative stress, regulating the vascular insulin signaling pathway and restoring vasodilator response to insulin in the SHRs.
The Effect of Buckwheat (Fagopyrum esculentum Moench) Groats Addition to the Lard Diet on Antioxidant Parameters of Plasma and Selected Tissues in Wistar Rats
- Chemistry
- 2013
Buckwheat groats indicate a beneficial effect in inhibiting protein and lipid peroxidation in rats and improved lipid profile, suggesting that buckwheatGroats exert a significant antioxidant potential and may be used as normal food constituent to ameliorate the oxidant-induced damage in organism.
Effect of rutin from tartary buckwheat sprout on serum glucose-lowering in animal model of type 2 diabetes
- BiologyActa pharmaceutica
- 2016
Rutin can play a critical role in down-regulation of serum glucose level in type 2 diabetes and down-regulated the expression levels of protein-tyrosine phosphatase 1B in a dose-dependent manner.
Buckwheat as a Functional Food and Its Effects on Health.
- Chemistry, MedicineJournal of agricultural and food chemistry
- 2015
Recent research regarding the health benefits of BW is reviewed, in vitro and in vivo, focusing on the specific role of its bioactive compounds and on the mechanisms by which these effects are exerted.
The analysis of fagopyritols from tartary buckwheat and their anti-diabetic effects in KK-Ay type 2 diabetic mice and HepG2 cells
- BiologyJournal of Functional Foods
- 2018
Consumption of buckwheat modulates the post-prandial response of selected gastrointestinal satiety hormones in individuals with type 2 diabetes mellitus.
- MedicineMetabolism: clinical and experimental
- 2013
References
SHOWING 1-10 OF 17 REFERENCES
Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys.
- Biology, MedicineEndocrinology
- 1993
D-CI administration, therefore, lowered elevated plasma glucose in streptozotocin-treated hyperglycemic rats, normal rats given a glucose load, and spontaneously insulin-resistant monkeys with or without noninsulin-dependent diabetes mellitus.
Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats.
- Biology, ChemistryHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
- 2000
Three components of the pH 2.0 putative mediator of insulin action and D-Chiro-inositol and manganese are examined in low dose streptozotocin-treated rats, having an important role in glucose uptake, insulin release and mediator generation.
Urinary chiro-Inositol and myo-inositol Excretion is Elevated in the Diabetic db/db Mouse and Streptozotocin Diabetic Rat
- Biology, MedicineExperimental biology and medicine
- 2003
Urinary excretion of chiro-inositol and myo-inosltol excretion was elevated in animal models of type 1 and type 2 diabetes mellitus, concomitant with hyperglycemia and glucosuria.
Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.
- Biology, MedicineThe Journal of clinical investigation
- 1975
It is suggested that insulin deficiency, and possibly hyperglycemia, are primary factors in the development of imparied MNCV in acute experimental diabetes.
Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol.
- BiologyBiochemical and biophysical research communications
- 1988
Insulin mediators in man: effects of glucose ingestion and insulin resistance
- Biology, MedicineDiabetologia
- 1997
The data suggest that the pH 2.0 IPG plays an important role in mediating insulin's effect on peripheral glucose utilization in man under physiological conditions, and shows a defective change in the bioactivity of an insulin mediator isolated from insulin-resistant humans after hyperinsulinaemia, suggesting that inadequate generation/release of IPGs is associated with insulin resistance.
Diabetes and the Role of Inositol-Containing Lipids in Insulin Signaling
- Biology, MedicineMolecular medicine
- 1999
Among metabolic diseases, diabetes is considered one of the most prevalent throughout the world. Currently, statistics show that over 10% of the world’s aged population (60 years and older) suffers…
Insulin Mediators and the Control of Pyruvate Dehydrogenase Complex a
- Biology, ChemistryAnnals of the New York Academy of Sciences
- 1989
It is known at the molecular level that glycogen synthase and pyruvate dehydrogenase complex (PDC), the first rate-limiting enzymes in the respective metabolic pathways involved in these effects, are each activated by insulin-induced dephosphorylation.
Is there evidence for phospho-oligosaccharides as insulin mediators?
- Biology, ChemistryGlycobiology
- 1997
The biochemical data that have been presented for and against a role for a POS factor in insulin signaling over the last decade and a half are considered.
The role of glycosyl-phosphatidylinositol in signal transduction.
- Biology, ChemistryThe international journal of biochemistry & cell biology
- 1998